Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCSW) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to $2.8 million.

  • HeartSciences' Shares Outstanding (Diluted Average) rose 20306.95% to $2.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $2.8 million, marking a year-over-year increase of 20306.95%. This contributed to the annual value of $938257.0 for FY2025, which is 16615.71% up from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Shares Outstanding (Diluted Average) is $2.8 million, which was up 20306.95% from $1.3 million recorded in Q3 2025.
  • HeartSciences' Shares Outstanding (Diluted Average)'s 5-year high stood at $8.2 million during Q1 2023, with a 5-year trough of $79506.0 in Q2 2023.
  • For the 5-year period, HeartSciences' Shares Outstanding (Diluted Average) averaged around $2.5 million, with its median value being $1.1 million (2025).
  • As far as peak fluctuations go, HeartSciences' Shares Outstanding (Diluted Average) tumbled by 9866.22% in 2023, and later skyrocketed by 73524.82% in 2024.
  • HeartSciences' Shares Outstanding (Diluted Average) (Quarter) stood at $3.3 million in 2021, then skyrocketed by 147.76% to $8.2 million in 2022, then tumbled by 98.66% to $109841.0 in 2023, then surged by 735.25% to $917445.0 in 2024, then soared by 203.07% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q4 2025, $1.3 million for Q3 2025, and $938257.0 during Q2 2025.